These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36828801)

  • 41. Biomolecule-corona formation confers resistance of bacteria to nanoparticle-induced killing: Implications for the design of improved nanoantibiotics.
    Siemer S; Westmeier D; Barz M; Eckrich J; Wünsch D; Seckert C; Thyssen C; Schilling O; Hasenberg M; Pang C; Docter D; Knauer SK; Stauber RH; Strieth S
    Biomaterials; 2019 Feb; 192():551-559. PubMed ID: 30530244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer-associated-platelet-inspired nanomedicines for cancer therapy.
    Geranpayehvaghei M; Dabirmanesh B; Khaledi M; Atabakhshi-Kashi M; Gao C; Taleb M; Zhang Y; Khajeh K; Nie G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1702. PubMed ID: 33538125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibacterial activity of curcumin and its essential nanoformulations against some clinically important bacterial pathogens: A comprehensive review.
    Shome S; Talukdar AD; Upadhyaya H
    Biotechnol Appl Biochem; 2022 Dec; 69(6):2357-2386. PubMed ID: 34826356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimuli-responsive polypeptide nanoassemblies: Recent progress and applications in cancer nanomedicine.
    Song Y; Ding Y; Dong CM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1742. PubMed ID: 34310063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity.
    Ryu JH; Yoon HY; Sun IC; Kwon IC; Kim K
    Adv Mater; 2020 Dec; 32(51):e2002197. PubMed ID: 33051905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-lamellar lyotropic liquid crystalline nanoparticles enhance the antibacterial effects of rifampicin against Staphylococcus aureus.
    Tran N; Hocquet M; Eon B; Sangwan P; Ratcliffe J; Hinton TM; White J; Ozcelik B; Reynolds NP; Muir BW
    J Colloid Interface Sci; 2018 Jun; 519():107-118. PubMed ID: 29486430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
    Monteiro PF; Travanut A; Conte C; Alexander C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unconventional screening approaches for antibiotic discovery.
    Farha MA; Brown ED
    Ann N Y Acad Sci; 2015 Sep; 1354():54-66. PubMed ID: 26100135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibacterial Efficacy of Polysaccharide Capped Silver Nanoparticles Is Not Compromised by AcrAB-TolC Efflux Pump.
    Mishra M; Kumar S; Majhi RK; Goswami L; Goswami C; Mohapatra H
    Front Microbiol; 2018; 9():823. PubMed ID: 29780364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ovotransferrin Antibacterial Peptide Coupling Mesoporous Silica Nanoparticle as an Effective Antibiotic Delivery System for Treating Bacterial Infection In Vivo.
    Ma B; Chen Y; Hu G; Zeng Q; Lv X; Oh DH; Fu X; Jin Y
    ACS Biomater Sci Eng; 2022 Jan; 8(1):109-118. PubMed ID: 34936344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gold Nanoparticles with Antibiotic-Metallopolymers toward Broad-Spectrum Antibacterial Effects.
    Yang P; Pageni P; Rahman MA; Bam M; Zhu T; Chen YP; Nagarkatti M; Decho AW; Tang C
    Adv Healthc Mater; 2019 Mar; 8(6):e1800854. PubMed ID: 30480381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metal and Metal Oxide Nanoparticle as a Novel Antibiotic Carrier for the Direct Delivery of Antibiotics.
    Kotrange H; Najda A; Bains A; Gruszecki R; Chawla P; Tosif MM
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in
    Imperi F; Fiscarelli EV; Visaggio D; Leoni L; Visca P
    Front Cell Infect Microbiol; 2019; 9():49. PubMed ID: 30915278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In Situ Capture of Bacterial Toxins for Antivirulence Vaccination.
    Wei X; Gao J; Wang F; Ying M; Angsantikul P; Kroll AV; Zhou J; Gao W; Lu W; Fang RH; Zhang L
    Adv Mater; 2017 Sep; 29(33):. PubMed ID: 28656663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antivirulence as a new antibacterial approach for chemotherapy.
    Escaich S
    Curr Opin Chem Biol; 2008 Aug; 12(4):400-8. PubMed ID: 18639647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.